Does AGALSIDASE BETA Cause Unevaluable event? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Unevaluable event have been filed in association with AGALSIDASE BETA (Fabrazyme). This represents 0.9% of all adverse event reports for AGALSIDASE BETA.
55
Reports of Unevaluable event with AGALSIDASE BETA
0.9%
of all AGALSIDASE BETA reports
5
Deaths
14
Hospitalizations
How Dangerous Is Unevaluable event From AGALSIDASE BETA?
Of the 55 reports, 5 (9.1%) resulted in death, 14 (25.5%) required hospitalization.
Is Unevaluable event Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AGALSIDASE BETA. However, 55 reports have been filed with the FAERS database.
What Other Side Effects Does AGALSIDASE BETA Cause?
Malaise (409)
Pain (395)
Pyrexia (362)
Fatigue (338)
Nausea (303)
Weight decreased (272)
Headache (269)
Dyspnoea (266)
Chills (259)
Vomiting (244)
What Other Drugs Cause Unevaluable event?
ADALIMUMAB (4,242)
ETANERCEPT (3,902)
LENALIDOMIDE (3,331)
OXYCODONE (3,145)
AMBRISENTAN (2,336)
SODIUM OXYBATE (2,328)
CARBIDOPA\LEVODOPA (1,632)
DUPILUMAB (1,410)
MORPHINE (1,161)
ACETAMINOPHEN\HYDROCODONE (1,118)
Which AGALSIDASE BETA Alternatives Have Lower Unevaluable event Risk?
AGALSIDASE BETA vs AGOMELATINE
AGALSIDASE BETA vs ALAWAY
AGALSIDASE BETA vs ALBENDAZOLE
AGALSIDASE BETA vs ALBIGLUTIDE
AGALSIDASE BETA vs ALBUMIN